ABLEMIND
LIVE

Serial Number

79345903

Owner

WordDiagnostics AB

Attorney

Maureen E. Kelly

Filing Date

May 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ABLEMIND Trademark

Serial Number: 79345903 • Registration: 7582830

ABLEMIND is a trademark filed by WordDiagnostics AB on May 3, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

WordDiagnostics AB

c/o Minc, Anckargripsgatan 3

Entity Type: 64

Trademark Details

Filing Date

May 3, 2022

Registration Date

December 3, 2024

Published for Opposition

October 1, 2024

Goods & Services

downloadable and recorded computer software for use in operating medical decision support systems; downloadable and recorded interactive computer software enabling exchange of information; downloadable and recorded character recognition software; downloadable and recorded information retrieval software; downloadable and recorded computer software to enable searching and retrieval of data; downloadable and recorded software for word processing; downloadable and recorded software for processing images, graphics, audio, video and text

Medical services; consulting services relating to health care; mental health treatment services; services of a psychologist; mental health services; personality testing namely for psychological purposes; psychological counseling; psychological counseling of staff; occupational psychology therapy services; occupational therapy services; conducting of psychological assessments and examination; personality testing for psychological purposes; psychological assessment services

providing information, advice and consultancy services in the field of computer software; design, maintenance, development and updating of computer software; design and development of software in the field of mobile applications; computer programming in the medical field; writing of computer programs for medical applications; design and development of data processing software; design and development of software for importing and managing data; design and development of computer software for evaluation and calculation of data; design and development of word processing software; medical research

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 17, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 25, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 25, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 3, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 14, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 14, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 14, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 14, 2024 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 21, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 3, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 3, 2024 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 16, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 16, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2023 TROA
REFUSAL PROCESSED BY IB
May 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Apr 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 6, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 2, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 28, 2022 REPR